EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease

Maria Gevezova, Maria Kazakova, Anastasia Trenova, Victoria Sarafian iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242216297 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Maria Gevezova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biology, Medical University, 4000 Plovdiv, Bulgaria. Hauptthemen laut MEDLINE: Parkinson Disease, Neurodegenerative Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinson’s disease (PD) is the second most common neurodegenerative disease worldwide. A growing body of evidence suggests that mitochondrial dysfunction and inflammation play a crucial role as a pathogenetic mechanism in PD. The glycoprotein YKL-40 (CHI3L1) is a potential biomarker involved in inflammation and tumor processes. The aim of the present study was to investigate the metabolic profile of PBMCs from PD patients and to search for a possible relationship between cellular bioenergetics and YKL-40. The study included 18 naïve PD patients and an age-matched control group (HC, n = 7). Patients were diagnosed according to the MDS-PD, the UPDRS, and the Hoen–Yahr scales. Mitochondrial activity was measured by a metabolic analyzer on isolated PBMCs from PD patients. Gene (qPCR) and protein (ELISA) expression levels of YKL40 were investigated. New data are reported revealing changes in the mitochondrial activity and YKL-40 levels in PD patients. Bioenergetic parameters showed increased respiratory reserve capacity in PD compared to HC. The protein levels of YKL-40 were threefold higher in PD. We found a correlation between the YKL-40 protein levels and basal respiration and between YKL-40 and ATP production. These observations suggest an interplay between YKL-40 and mitochondrial function in PD. We assume that the YKL-40 gene and protein levels in combination with changes in mitochondrial function might serve as an additional tool to monitor the clinical course of PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseNeurodegenerative DiseasesHumansChitinase-3-Like Protein 1InflammationMetabolome

Stichwörter der Autor:innen

Parkinson’s diseaseYKL-40mitochondrial dysfunction

Substanzen

Chitinase-3-Like Protein 1

Autor:innen und Institutionen

  • Department of Medical Biology, Medical University, 4000 Plovdiv, Bulgaria.
  • Research Institute at MU-Plovdiv, 4000 Plovdiv, Bulgaria.
  • Department of Neurology, Medical University, 4000 Plovdiv, Bulgaria.
  • University Hospital "Kaspela", 4000 Plovdiv, Bulgaria.

ORCID-Profile: Victoria Sarafian

Förderung

  • European Union-NextGenerationEU, through the National Recovery and Resilience Plan of the Republic of Bulgaria

Zitieren

APA

Gevezova, M., Kazakova, M., Trenova, A., & Sarafian, V. (2023). YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242216297

Vancouver

Gevezova M, Kazakova M, Trenova A, Sarafian V. YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242216297

BibTeX
@article{Gevezova2023,
  author = {Gevezova, Maria and Kazakova, Maria and Trenova, Anastasia and Sarafian, Victoria},
  title = {YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242216297}
}
Kostenlos starten →